Halaman 3 - Kanker lidah Dokter Terbaik - TOP-76 dokter

Profesor Kyzas memimpin uji coba MANTRA, uji coba terkontrol acak terbesar di bidang bedah mulut dan maksilofasial, dan berspesialisasi dalam perawatan kanker lidah stadium lanjut.

• Menerbitkan lebih dari 70 makalah ilmiah di jurnal berdampak tinggi
• Menjadi pelopor dalam perencanaan bedah rekonstruksi yang dipersonalisasi dengan cetakan 3D
• Menjadi ahli bedah mikrovaskular bersertifikat dengan pengalaman bedah kepala dan leher yang luas
• Menjadi Direktur Klinis untuk layanan kanker yang mencakup lebih dari 1 juta orang
• Menjadi Pemimpin Redaksi British Journal of Oral and Maxillofacial Surgery

Assoc. Prof. Nail Paksoy berspesialisasi dalam onkologi medis di Rumah Sakit Medipol Bahçelievler, dengan fokus pada pengobatan kanker lidah.

• Sertifikasi ESMO dalam Onkologi Medis
• Berpartisipasi dalam berbagai uji klinis internasional untuk pengobatan kanker
• Menerbitkan penelitian tentang berbagai topik onkologi, termasuk kemanjuran pengobatan
• Menjalani pelatihan fellowship di Institut Onkologi Universitas Istanbul

Dr. Alemdar berspesialisasi dalam onkologi medis dengan fokus pada kanker lidah, membawa pelatihan ekstensif dari Universitas Akdeniz.

• Tersertifikasi dewan dalam onkologi medis sejak 2018
• Lebih dari 15 tahun pengalaman dalam onkologi dan penyakit dalam
• Berpraktik di Medical Park Antalya Hospital Complex

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Erkan Karatas sangat terlatih dalam bidang otolaringologi serta bedah kepala dan leher, dengan pengalaman internasional yang luas di berbagai institusi ternama.

• Spesialisasi dalam bedah kepala dan leher di berbagai pusat terkemuka di Eropa dan AS
• Menempuh pelatihan di Hannover Medical School dan institusi terkemuka lainnya
• Menjadi anggota di berbagai asosiasi otolaringologi serta bedah kepala dan leher internasional

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Topcu telah menempuh pelatihan di pusat kanker bergengsi seperti MD Anderson dan Sunnybrook Odette, dengan spesialisasi pada kanker kepala dan leher termasuk kanker lidah.

• Residensi onkologi medis di Universitas Teknik Karadeniz
• Anggota ESMO dan ASCO – organisasi onkologi global terkemuka
• Menangani berbagai jenis kanker dengan fokus pada kasus-kasus kompleks
• Bekerja di Rumah Sakit Universitas Biruni dengan tim multidisiplin

Spesialis onkologi radiasi di Universitas Marmara – Dr. Sahibov berfokus pada perencanaan perawatan yang tepat untuk kanker lidah.

• Menjalani pendidikan di Fakultas Kedokteran Universitas Marmara
• Menyelesaikan spesialisasi onkologi radiasi pada tahun 2016
• Bekerja di Rumah Sakit Emsey dengan peralatan radioterapi canggih

Dr. Ozdemir membawa pengalaman spesialis THT dan bedah kepala-leher selama puluhan tahun untuk menangani kasus kanker lidah di Ento Surgical Medical Center.

• Lulusan Fakultas Kedokteran Universitas Hacettepe – salah satu sekolah kedokteran terbaik di Turki
• Mantan kepala departemen THT di Universitas Namik Kemal
• Pengalaman bedah selama 35+ tahun
• Menjalani pelatihan di Pusat Medis Universitas Hacettepe

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).